Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 2003

View Archived Issues

Shire BioChem scientists report new agents for hepatitis C virus

Novel antifungal macrolides isolated and tested by Ajinomoto scientists

Calcium antagonists and their use in IBS reported by Ajinomoto

Ono identifies novel cysteine protease inhibitors

Boehringer Ingelheim claims new cathepsin inhibitors for osteoporosis, arthritis, etc.

HMG-CoA-inhibitory simvastatin analogues covered by Ranbaxy patent

New CRF1 receptor modulators and their use in anxiety, depression and bowel disorders

Allosteric AMPA modulators discovered by Boehringer Ingelheim researchers

Phase II Liprostin study cleared to begin

GTx and Wyeth enter agreement for VSV-based therapeutics and vaccines

Genome Therapeutics and MerLion form antiinfective drug discovery collaboration

Solvay and Innogenetics extend research collaboration

Epicyte advances production of human HIV antibodies in plants

NicOx and Biolipox expand research on NO-donating respiratory drugs

Tarceva phase III trial in pancreatic cancer achieves target enrollment

AlphaRx acquires exclusive rights to VT-1

Alliance and Baxter to restructure Oxygent agreement

High-affinity sigma receptor ligand SSR-125392A effective in animal models of GVHD and RA

Ref-1/AP-1 validated as therapeutic target for asthma in recent PNAS article

FDA issues complete response letter for Aldurazyme

U.S. phase II trial of antibody targeting IL-15 cleared

First clinical study of IPL-512602 under way in the U.S.

Second filing announced for YM-905

Amylin acquires rights to GLP-1 program from Restoragen

Triangle now part of Gilead

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...